SPY295.44+0.56 0.19%
DIA244.88-0.14 -0.06%
IXIC9,324.59+39.71 0.43%

H.C. Wainwright Reiterates Buy on Mirati Therapeutics, Lowers Price Target to $126

H.C. Wainwright reiterates Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $134 to $126.

Benzinga · 02/28/2020 12:11

H.C. Wainwright reiterates Mirati Therapeutics (NASDAQ:MRTX) with a Buy and lowers the price target from $134 to $126.